快速血液调节(QB)与服用红细胞血液透析的CKD患者血浆尿素转导比的有效性

Endro Haksara, Ainnur Rahmanti
{"title":"快速血液调节(QB)与服用红细胞血液透析的CKD患者血浆尿素转导比的有效性","authors":"Endro Haksara, Ainnur Rahmanti","doi":"10.55606/sisthana.v6i1.70","DOIUrl":null,"url":null,"abstract":"The main function of the kidneys under normal conditions is to regulate fluids and electrolytes and the acid-base composition of body fluids, remove metabolic wastes that are no longer needed by the body, regulate blood pressure and hormonal function. Chronic Kidney Disease (CKD) is the final stage of chronic kidney failure where GFR <15 ml/min/1.73m2 so that the body fails to maintain metabolism and fluid and electrolyte balance, causing uremia, namely retention of urea and other nitrogenous wastes in the blood (Smeltzer et al. al, 2008; National Kidney Foundation in Kallenbach, et al, 2005). With the increasingly real decline in kidney function or worsening of symptoms of uremia, renal replacement therapy is required for survival, namely dialysis and organ transplantation. There are two methods of dialysis, one of which is Hemodialysis (Potter, 2005; Smelzer, 2008). Cases of chronic kidney failure in the world have increased by more than 50%, in the United States which is a very developed country every year there are about 20 million adults suffering from chronic kidney failure and undergoing hemodialysis in more than 100,000 patients, while in Indonesia, according to the Indonesian Kidney Diatrans Foundation, YDGI), in 2007 there were about 100,000 chronic kidney failure patients but only a few patients were able to undergo hemodialysis. Kidney replacement therapy in Indonesia was started in 1972 in Jakarta (Dr. Cipto Mangunkusumo Hospital/FKUI), in Bandung in 1976 (Hasan Sadikin Hospital/FK UNPAD).","PeriodicalId":184873,"journal":{"name":"JURNAL KEPERAWATAN SISTHANA","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EFEKTIFITAS PENGATURAN QUICK OF BLOOD (QB) TERHADAP RASIO REDUKSI UREUM PLASMA PADA PASIEN CKD YANG MENJALANI HEMODIALISIS DI RST DR. SOEDJONO MAGELANG\",\"authors\":\"Endro Haksara, Ainnur Rahmanti\",\"doi\":\"10.55606/sisthana.v6i1.70\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main function of the kidneys under normal conditions is to regulate fluids and electrolytes and the acid-base composition of body fluids, remove metabolic wastes that are no longer needed by the body, regulate blood pressure and hormonal function. Chronic Kidney Disease (CKD) is the final stage of chronic kidney failure where GFR <15 ml/min/1.73m2 so that the body fails to maintain metabolism and fluid and electrolyte balance, causing uremia, namely retention of urea and other nitrogenous wastes in the blood (Smeltzer et al. al, 2008; National Kidney Foundation in Kallenbach, et al, 2005). With the increasingly real decline in kidney function or worsening of symptoms of uremia, renal replacement therapy is required for survival, namely dialysis and organ transplantation. There are two methods of dialysis, one of which is Hemodialysis (Potter, 2005; Smelzer, 2008). Cases of chronic kidney failure in the world have increased by more than 50%, in the United States which is a very developed country every year there are about 20 million adults suffering from chronic kidney failure and undergoing hemodialysis in more than 100,000 patients, while in Indonesia, according to the Indonesian Kidney Diatrans Foundation, YDGI), in 2007 there were about 100,000 chronic kidney failure patients but only a few patients were able to undergo hemodialysis. Kidney replacement therapy in Indonesia was started in 1972 in Jakarta (Dr. Cipto Mangunkusumo Hospital/FKUI), in Bandung in 1976 (Hasan Sadikin Hospital/FK UNPAD).\",\"PeriodicalId\":184873,\"journal\":{\"name\":\"JURNAL KEPERAWATAN SISTHANA\",\"volume\":\"60 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JURNAL KEPERAWATAN SISTHANA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55606/sisthana.v6i1.70\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JURNAL KEPERAWATAN SISTHANA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55606/sisthana.v6i1.70","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肾脏在正常情况下的主要功能是调节体液和电解质以及体液的酸碱组成,清除身体不再需要的代谢废物,调节血压和激素功能。慢性肾脏病(Chronic Kidney Disease, CKD)是慢性肾衰竭的最后阶段,GFR <15 ml/min/1.73m2,机体无法维持代谢和体液电解质平衡,导致尿尿症,即尿素和其他含氮废物滞留在血液中(Smeltzer et al., 2008;Kallenbach等人,2005)。随着肾功能的日益下降或尿毒症症状的加重,生存需要肾脏替代治疗,即透析和器官移植。透析有两种方法,其中一种是血液透析(Potter, 2005;Smelzer, 2008)。世界上慢性肾衰竭的病例增加了50%以上,在美国这个非常发达的国家,每年大约有2000万成年人患有慢性肾衰竭,其中有超过10万名患者接受了血液透析,而在印度尼西亚,根据印度尼西亚肾脏透析基金会(YDGI)的数据,2007年大约有10万名慢性肾衰竭患者,但只有少数患者能够接受血液透析。印度尼西亚的肾脏替代疗法于1972年在雅加达(Cipto Mangunkusumo医生医院)开始,1976年在万隆(Hasan Sadikin医院/FK联合国发展基金)开始。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
EFEKTIFITAS PENGATURAN QUICK OF BLOOD (QB) TERHADAP RASIO REDUKSI UREUM PLASMA PADA PASIEN CKD YANG MENJALANI HEMODIALISIS DI RST DR. SOEDJONO MAGELANG
The main function of the kidneys under normal conditions is to regulate fluids and electrolytes and the acid-base composition of body fluids, remove metabolic wastes that are no longer needed by the body, regulate blood pressure and hormonal function. Chronic Kidney Disease (CKD) is the final stage of chronic kidney failure where GFR <15 ml/min/1.73m2 so that the body fails to maintain metabolism and fluid and electrolyte balance, causing uremia, namely retention of urea and other nitrogenous wastes in the blood (Smeltzer et al. al, 2008; National Kidney Foundation in Kallenbach, et al, 2005). With the increasingly real decline in kidney function or worsening of symptoms of uremia, renal replacement therapy is required for survival, namely dialysis and organ transplantation. There are two methods of dialysis, one of which is Hemodialysis (Potter, 2005; Smelzer, 2008). Cases of chronic kidney failure in the world have increased by more than 50%, in the United States which is a very developed country every year there are about 20 million adults suffering from chronic kidney failure and undergoing hemodialysis in more than 100,000 patients, while in Indonesia, according to the Indonesian Kidney Diatrans Foundation, YDGI), in 2007 there were about 100,000 chronic kidney failure patients but only a few patients were able to undergo hemodialysis. Kidney replacement therapy in Indonesia was started in 1972 in Jakarta (Dr. Cipto Mangunkusumo Hospital/FKUI), in Bandung in 1976 (Hasan Sadikin Hospital/FK UNPAD).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信